Liver biopsy may not be the optimal option for assessing treatment efficacy in chronic hepatitis delta (CHD) infection
Aysun Kartal, Mehmet Berk Örüncü, Berna Savaş, Ramazan Idilman, Fatma Yavaş, Cihan Yurdadın
(Turk J Gastroenterol 2019; 30: 67-67) DOI: 10.5152/tjg.2019.44